Real-world Evidence Team

Julkaisut

• Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease Koponen, Marjaana; Rajamaki, Blair; Lavikainen, Piia; Bell, J. Simon; Taipale, Heidi; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease Journal of the american medical directors association [in press]: 1-7. 2022
• Coronary artery revascularizations and cognitive decline - A systematic review Lappalainen, Laura; Rajamaki, Blair; Tolppanen, Anna-Maija; Hartikainen, Sirpa. 2022. Coronary artery revascularizations and cognitive decline - A systematic review Current problems in cardiology [in press, corrected proof]: 100960. 2022
• Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease Tarvainen, Anniina; Hartikainen, Sirpa; Taipale, Heidi; Tanskanen, Antti; Koponen, Marjaana; Tolppanen, Anna-Maija. 2021. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease International journal of geriatric psychiatry 36 7: 1075-1084. 2021
• Automated multi-dose dispensing in persons with and without Alzheimer's disease - impacts on pharmacotherapy Vallius, Sanna; Taipale, Heidi; Koponen, Marjaana; Tolppanen, Anna-Maija; Tanskanen, Antti; Hartikainen, Sirpa; Tiihonen, Miia. 2021. Automated multi-dose dispensing in persons with and without Alzheimer's disease - impacts on pharmacotherapy European journal of clinical pharmacology 2022; 78 3: 513-521. 2021
• Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer's Disease Vu, Mai; Koponen, Marjaana; Taipale, Heidi; Kettunen, Raimo; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2021. Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer's Disease Journals of gerontology series a: biological sciences and medical sciences 76 8: 1524-1530. 2021
• Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease Pisa, Federica; Reinold, Jonas; Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2021. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease Clinical epidemiology 13: 295-307. 2021
• Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study Hentilä, Eerik; Tiihonen, Miia; Taipale, Heidi; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2021. Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study Bmc geriatrics 21 1: 202. 2021
• Incidence of cataract surgeries in people with and without Alzheimer's disease Hokkinen, K; Kaarniranta, K; Jämsen, E; Lampela, P; Hartikainen, S; Tolppanen, AM. 2021. Incidence of cataract surgeries in people with and without Alzheimer's disease Acta ophthalmologica 2022; 100 1: 68-73. 2021
• Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders Kuusimäki, Tomi; Al-Abdulrasul, Haidar; Kurki, Samu; Hietala, Jarmo; Hartikainen, Sirpa; Koponen, Marjaana; Tolppanen, Anna-Maija; Kaasinen, Valtteri. 2021. Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders Movement disorders 36 6: 1353-1361. 2021
• Patient-reported outcomes in coronary artery disease: the relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D Lappalainen, Laura; Stenvall, Harriet; Lavikainen, Piia; Miettinen, Heikki; Martikainen, Janne; Sintonen, Harri; Tolppanen, Anna-Maija; Roine, Risto P; Hartikainen, Juha. 2021. Patient-reported outcomes in coronary artery disease: the relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D Health and quality of life outcomes 19 1: 206. 2021
• Pelvic organ prolapse surgery and overactive bladder symptoms - a population-based cohort (FINPOP) Karjalainen, Päivi K; Tolppanen, Anna-Maija; Mattsson, Nina K; Wihersaari, Olga AE; Jalkanen, Jyrki T; Nieminen, Kari. 2021. Pelvic organ prolapse surgery and overactive bladder symptoms - a population-based cohort (FINPOP) International urogynecology journal 2022; 33 1: 95-105. 2021
• The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study Rajamaki, Blair; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2021. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study Bmc geriatrics 21 1: 173. 2021
• Agreement between patient global impression scale of improvement, pelvic floor distress inventory and 15D in measuring the outcome of pelvic organ prolapse surgery Mattsson, Nina K; Karjalainen, Päivi; Heikkinen, Anna-Mari; Nieminen, Kari; Jalkanen, Jyrki; Tolppanen, Anna-Maija. 2020. Agreement between patient global impression scale of improvement, pelvic floor distress inventory and 15D in measuring the outcome of pelvic organ prolapse surgery Neurourology and urodynamics 39 8: 2171-2178. 2020
• Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease Neurology 94 20: e2099-e2108. 2020
• Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and Mental Health Global Epidemiology Network (NeuroGEN) Ilomäki, J; Bell, JS; Chan, AYL; Tolppanen, AM; Luo, H; Wei, L; Lai, EC; Shin, JY; De Paoli, G; Pajouheshnia, R; Ho, FK; Reynolds, L; Lau, KK; Crystal, S; Lau, WCY; Man, KKC; Brauer, R; Chan, EW; Shen, CY; Kim, JH; et al. [incl. Hartikainen, S; Koponen, M]. 2020. Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and Mental Health Global Epidemiology Network (NeuroGEN) Cns drugs 34 9: 897-913. 2020
• Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease Tolppanen, Anna-Maija; Taipale, Heidi; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa. 2020. Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease Bmc geriatrics 20 1: 441. 2020
• Complications of Pelvic Organ Prolapse Surgery in the 2015 Finnish Pelvic Organ Prolapse Surgery Survey Study Wihersaari, Olga; Karjalainen, Päivi; Tolppanen, Anna-Maija; Mattsson, Nina; Jalkanen, Jyrki; Nieminen, Kari. 2020. Complications of Pelvic Organ Prolapse Surgery in the 2015 Finnish Pelvic Organ Prolapse Surgery Survey Study Obstetrics and gynecology 136 6: 1135-1144. 2020
• Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory Braithwaite, B; Paananen, J; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, A-M. 2020. Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory International journal of medical informatics 141: 104142. 2020
• Minimal important difference and patient acceptable symptom state for PFDI-20 and POPDI-6 in POP surgery Karjalainen, Päivi K; Mattsson, Nina K; Jalkanen, Jyrki T; Nieminen, Kari; Tolppanen, Anna-Maija. 2020. Minimal important difference and patient acceptable symptom state for PFDI-20 and POPDI-6 in POP surgery International urogynecology journal 2021; 32 12: 3169-3176. 2020
• Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease Journal of the american medical directors association 20 6: 751-758. 2019
• Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Cui, LL; Golubczyk, D; Tolppanen, AM; Boltze, J; Jolkkonen, J. 2019. Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Annals of neurology 86 1: 5-16. 2019
• Methodological Challenges in Epidemiological Studies Methodological Challenges in Epidemiological Studies. Ilomäki, Jenni; Tolppanen, Anna-Maija / Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Volume 2. 2019. 2019